BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5002750)

  • 21. [Thyroid gland function of patients with diabetes in long-term use of glibornuride].
    Reinwein D
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2221. PubMed ID: 4125093
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pharmacological aspects of comparative studies on different blood sugar-lowering sulfonylureas].
    Beyer J; Haupt E; Cordes U; Sell G; Schöffling K
    Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1668-75. PubMed ID: 4205544
    [No Abstract]   [Full Text] [Related]  

  • 23. Porin proteins in mitochondria from rat pancreatic islet cells and white adipocytes: identification and regulation of hexokinase binding by the sulfonylurea glimepiride.
    Müller G; Korndörfer A; Kornak U; Malaisse WJ
    Arch Biochem Biophys; 1994 Jan; 308(1):8-23. PubMed ID: 8311478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of sulphonylureas on the volume-sensitive anion channel in rat pancreatic beta-cells.
    Best L; Benington S
    Br J Pharmacol; 1998 Oct; 125(4):874-8. PubMed ID: 9831927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The in vitro effect of two oral hypoglycemic agents on hepatic protein synthesis.
    DeChatelet LR; McDonald HJ
    Proc Soc Exp Biol Med; 1966 Jul; 122(3):765-8. PubMed ID: 5918947
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of sulphonylureas on spontaneous motility and induced contractions in rat isolated uterus.
    Villar A; Ivora MD; D'Ocon MP; Anselmi E
    J Pharm Pharmacol; 1986 Oct; 38(10):778-80. PubMed ID: 2879004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral sulfonylurea agents suppress hepatic glucose production in non-insulin-dependent diabetic individuals.
    DeFronzo RA; Simonson DC
    Diabetes Care; 1984; 7 Suppl 1():72-80. PubMed ID: 6428844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of hypoglycemic sulfonamides on glucagon and insulin secretion in ducks and dogs.
    Kajinuma H; Kuzuya TT; Ide T
    Diabetes; 1974 May; 23(5):412-7. PubMed ID: 4208464
    [No Abstract]   [Full Text] [Related]  

  • 29. [Action of the sulfonylureas tolbutamide and glypentide on the lacticdehydrogenase plasma levels (author's transl)].
    García-Rafanell J; Morell-Mestre J
    Rev Esp Fisiol; 1974 Jun; 30(2):91-6. PubMed ID: 4421448
    [No Abstract]   [Full Text] [Related]  

  • 30. [Inotropic effect of tolbutamide and glipentide in isolated guinea pig atria (author's transl)].
    Sánchez-Casals MS; Morell-Mestre J
    Rev Esp Fisiol; 1974 Dec; 30(4):273-6. PubMed ID: 4456482
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of blood sugar decreasing sulfonylureas on the in vitro metabolism of glucose and amino acids in the beta-cells of the pancreas in mice].
    Hellerström C; Westman S; Stork H; Schmidt FH
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1464-7. PubMed ID: 4899088
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of tolbutamide and glyburide on pyruvate kinase flux in isolated rat hepatocytes.
    Judd RL; Kunjathoor VV; Pillai UA; Ferguson PW; Medon PJ
    Life Sci; 1992; 50(23):PL203-8. PubMed ID: 1317934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Inhibition of ketogenesis in liver tissue by tolbutamide and glycodiazine in vitro].
    Hasselblatt A
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 262(2):152-64. PubMed ID: 4239707
    [No Abstract]   [Full Text] [Related]  

  • 34. Interference of the sulphonylurea antidiabeticum gliquidone with mitochondrial bioenergetics in the rat under in vitro conditions.
    Somogyi J; Vér A; Trója G; Végh E; Bühler C; Hatfaludi F; Csermely P; Popović S
    Acta Physiol Hung; 1995; 83(4):299-312. PubMed ID: 8863893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pharmacology of a new hypoglycaemic agent N-[4-(2-(2,3-dihydrobenzo(b)furan-7-carboxamid o)-ethyl)-benzenesulphonyl]-N'-cyclohexlurea (NOVO CS 476). III. General pharmacological studies.
    Jorgensen KD
    Acta Pharmacol Toxicol (Copenh); 1977 Feb; 40(2):234-40. PubMed ID: 402792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effect of hypoglycemic sulfonylurea preparations on the heart conduction system].
    Pogátsa G; Németh M
    Orv Hetil; 1980 Sep; 121(37):2255-7. PubMed ID: 6780962
    [No Abstract]   [Full Text] [Related]  

  • 37. Sulfonylureas inhibit metabolic flux through rat liver pyruvate carboxylase reaction.
    White CW; Rashed HM; Patel TB
    J Pharmacol Exp Ther; 1988 Sep; 246(3):971-4. PubMed ID: 3138409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Extrapancreatic effects of sulfonylurea compounds. II. Comparison of equimolar concentrations of tolbutamide, glibornuride, hydroxymethyltolbutamide, carboxytolbutamide, and carboxyglycylamide with reference to their blood-sugar-decreasing and antilipolytic effect on completely pancreatectomized dogs, chronically treated insulin].
    Beyer J; Cordes U; Sell G; Krall H; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2172. PubMed ID: 4679247
    [No Abstract]   [Full Text] [Related]  

  • 39. [On the influence of oral antidiabetics on protein biosynthesis in vitro (author's transl)].
    Tragl KH
    Arzneimittelforschung; 1976; 26(3):374-7. PubMed ID: 989329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic effects of hypoglycemic sulfonylureas. I. In vitro effect of sulfonylureas on leucine incorporation and metabolism and on respiration of rat tissues.
    De Schepper PJ
    Biochem Pharmacol; 1967 Dec; 16(12):2337-53. PubMed ID: 6075395
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.